About Multiple Sclerosis (MS)
Multiple Sclerosis (MS) is an autoimmune disease affecting up to an estimated 1 million individuals in the US, with females affected 2-3 times as frequently as males. Symptoms include:
- Weakness
- Fatigue
- Numbness and tingling
- Vision problems
- Loss of balance
- Difficulty concentrating or remembering
- Seizures
- Vertigo
- Difficulty walking
Many of these symptoms are not consistent — they vary in strength and come and go at random.
The MS Studies is enrolling relapsing forms of MS including:
- Relapsing-remitting MS (RRMS): the most common form of MS affecting approximately 85% of people with MS. It is characterized by clearly defined attacks — also known as relapses or flare-ups — followed by periods of partial or complete recovery (remission).
- Secondary progressive MS (SPMS): a secondary phase of MS characterized by progressive worsening of symptoms over time with no definite periods of remission. SPMS may develop years or decades following an initial diagnosis with relapsing MS.